At ALL, we believe everyone deserves the best quality of life possible. As a global biopharmaceutical company, we develop solutions that improve the lives of people with neurological and autoimmune conditions, while providing expert consultancy and strategic R&D guidance to biotech and pharmaceutical companies across the UK and EU.
A home for innovation
Innovation drives progress across every aspect of life, including the transformation of healthcare.
Get in touch with us
ALL Stories and Newsroom
Driving the future of rare disease diagnosis: OrphaNexis's next chapter
“Each step forward brings us closer to a world where patients can enjoy longer, healthier, better-quality lives.”
Sustainability
At ALL, sustainability is central to how we operate, shaping decisions that create positive social impact, strengthen communities, and safeguard the planet for generations to come.
Drug Discovery
We invest in emerging technologies, evolving science and new therapeutic modalities to advance drug discovery.
